These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 36335839)
1. Heteroplasmic Mutant Load Differences in Mitochondrial DNA-Associated Leigh Syndrome. Na JH; Lee YM Pediatr Neurol; 2023 Jan; 138():27-32. PubMed ID: 36335839 [TBL] [Abstract][Full Text] [Related]
2. Genotype-phenotype analysis of MT-ATP6-associated Leigh syndrome. Na JH; Lee YM Acta Neurol Scand; 2022 Apr; 145(4):414-422. PubMed ID: 34877647 [TBL] [Abstract][Full Text] [Related]
3. Multisystem mitochondrial diseases due to mutations in mtDNA-encoded subunits of complex I. Danhelovska T; Kolarova H; Zeman J; Hansikova H; Vaneckova M; Lambert L; Kucerova-Vidrova V; Berankova K; Honzik T; Tesarova M BMC Pediatr; 2020 Jan; 20(1):41. PubMed ID: 31996177 [TBL] [Abstract][Full Text] [Related]
4. Metabolic rescue in pluripotent cells from patients with mtDNA disease. Ma H; Folmes CD; Wu J; Morey R; Mora-Castilla S; Ocampo A; Ma L; Poulton J; Wang X; Ahmed R; Kang E; Lee Y; Hayama T; Li Y; Van Dyken C; Gutierrez NM; Tippner-Hedges R; Koski A; Mitalipov N; Amato P; Wolf DP; Huang T; Terzic A; Laurent LC; Izpisua Belmonte JC; Mitalipov S Nature; 2015 Aug; 524(7564):234-8. PubMed ID: 26176921 [TBL] [Abstract][Full Text] [Related]
5. Mutations in the ND5 subunit of complex I of the mitochondrial DNA are a frequent cause of oxidative phosphorylation disease. Blok MJ; Spruijt L; de Coo IF; Schoonderwoerd K; Hendrickx A; Smeets HJ J Med Genet; 2007 Apr; 44(4):e74. PubMed ID: 17400793 [TBL] [Abstract][Full Text] [Related]
6. Association Between Epilepsy and Leigh Syndrome With Na JH; Lee MJ; Lee CH; Lee YM Front Neurol; 2021; 12():752467. PubMed ID: 34956047 [No Abstract] [Full Text] [Related]
7. Whole mitochondrial genome analysis of a family with NARP/MILS caused by m.8993T>C mutation in the MT-ATP6 gene. Kara B; Arıkan M; Maraş H; Abacı N; Cakıris A; Ustek D Mol Genet Metab; 2012 Nov; 107(3):389-93. PubMed ID: 22819295 [TBL] [Abstract][Full Text] [Related]
8. Mitochondrial DNA mutations in late-onset Leigh syndrome. Wei Y; Cui L; Peng B J Neurol; 2018 Oct; 265(10):2388-2395. PubMed ID: 30128709 [TBL] [Abstract][Full Text] [Related]
9. Rapid identification of a novel complex I MT-ND3 m.10134C>A mutation in a Leigh syndrome patient. Miller DK; Menezes MJ; Simons C; Riley LG; Cooper ST; Grimmond SM; Thorburn DR; Christodoulou J; Taft RJ PLoS One; 2014; 9(8):e104879. PubMed ID: 25118196 [TBL] [Abstract][Full Text] [Related]
10. The m.3890G>A/MT-ND1 mtDNA rare pathogenic variant: Expanding clinical and MRI phenotypes. Vacchiano V; Caporali L; La Morgia C; Carbonelli M; Amore G; Bartolomei I; Cascavilla ML; Barboni P; Lamperti C; Catania A; Chan JW; Karanja R; Sadun AA; Liguori R; Bianchi A; Gavazzi G; Mascalchi M; Salvi F; Carelli V Mitochondrion; 2021 Sep; 60():142-149. PubMed ID: 34390870 [TBL] [Abstract][Full Text] [Related]
11. The mitochondrial DNA G13513A MELAS mutation in the NADH dehydrogenase 5 gene is a frequent cause of Leigh-like syndrome with isolated complex I deficiency. Chol M; Lebon S; Bénit P; Chretien D; de Lonlay P; Goldenberg A; Odent S; Hertz-Pannier L; Vincent-Delorme C; Cormier-Daire V; Rustin P; Rötig A; Munnich A J Med Genet; 2003 Mar; 40(3):188-91. PubMed ID: 12624137 [TBL] [Abstract][Full Text] [Related]
12. Phenotype-genotype correlations in Leigh syndrome: new insights from a multicentre study of 96 patients. Sofou K; de Coo IFM; Ostergaard E; Isohanni P; Naess K; De Meirleir L; Tzoulis C; Uusimaa J; Lönnqvist T; Bindoff LA; Tulinius M; Darin N J Med Genet; 2018 Jan; 55(1):21-27. PubMed ID: 29101127 [TBL] [Abstract][Full Text] [Related]
13. Leigh disease presenting in utero due to a novel missense mutation in the mitochondrial DNA-ND3. Leshinsky-Silver E; Lev D; Malinger G; Shapira D; Cohen S; Lerman-Sagie T; Saada A Mol Genet Metab; 2010 May; 100(1):65-70. PubMed ID: 20202874 [TBL] [Abstract][Full Text] [Related]
14. The mutation m.13513G>A impairs cardiac function, favoring a neuroectoderm commitment, in a mutant-load dependent way. Galera-Monge T; Zurita-Díaz F; Garesse R; Gallardo ME J Cell Physiol; 2019 Nov; 234(11):19511-19522. PubMed ID: 30950033 [TBL] [Abstract][Full Text] [Related]
15. Clinical, Neuroimaging, and Pathological Analyses of 13 Chinese Leigh Syndrome Patients with Mitochondrial DNA Mutations. Yu XL; Yan CZ; Ji KQ; Lin PF; Xu XB; Dai TJ; Li W; Zhao YY Chin Med J (Engl); 2018 Nov; 131(22):2705-2712. PubMed ID: 30425197 [TBL] [Abstract][Full Text] [Related]
16. [Variation in manifestations of heteroplasmic mtDNA mutation 8993 T>G in two families]. Tesarová M; Hansíková H; Hlavatá A; Klement P; Houst'ková H; Houstĕk J; Zeman J Cas Lek Cesk; 2002 Aug; 141(17):551-4. PubMed ID: 12404959 [TBL] [Abstract][Full Text] [Related]
17. Leigh disease associated with a novel mitochondrial DNA ND5 mutation. Taylor RW; Morris AA; Hutchinson M; Turnbull DM Eur J Hum Genet; 2002 Feb; 10(2):141-4. PubMed ID: 11938446 [TBL] [Abstract][Full Text] [Related]
18. Leigh syndrome T8993C mitochondrial DNA mutation: Heteroplasmy and the first clinical presentation in a Vietnamese family. Weerasinghe CAL; Bui BT; Vu TT; Nguyen HT; Phung BK; Nguyen VM; Pham VA; Cao VH; Phan TN Mol Med Rep; 2018 May; 17(5):6919-6925. PubMed ID: 29512743 [TBL] [Abstract][Full Text] [Related]